Most Squamous Cell Carcinomas are Found in the Head and Neck Region.

Published Date: 27 Apr 2023

According to recent data on Medicare beneficiaries in the US, squamous cell carcinomas are more frequently found in the head and neck region of the body than in other places.

Read Full News

Latest News

Benefits of TrumpRx Drug Site Are Limited, Experts Say

A new federal prescription drug site promises to save patients money on popular drugs. Here’s what physicians should know about TrumpRx.

Mediterranean Diet May Lower All-Type Stroke Risk in Women

Results of a large cohort study show adherence to a Mediterranean diet is linked to a lower risk for all stroke types in women.

HIV & Menopause: A Combo We’re Just Beginning to Understand

As patients with HIV live longer, menopause is becoming routine, but the science, safety data, and responsibility for managing it are still catching up.

Mortality Up for Medicare Beneficiaries During Late COVID-19

Medicare beneficiaries with cardiovascular disease or risk factors had increased mortality rates and fewer hospitalizations in the later stages of the COVID-19 pandemic.

Early Findings on Implantable Device Look Promising

The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.

Should Prenatal Growth Restriction Inform Adult Screening?

Fetal growth restriction and extreme prematurity alter cardiovascular and pulmonary trajectories, with effects that persist from infancy into adult life.

Todays Updates

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Navigating Advances in Cystic Fibrosis Care

Navigating Advances in Cystic Fibrosis Care

Todays Updates

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Navigating Advances in Cystic Fibrosis Care

Navigating Advances in Cystic Fibrosis Care

Latest News

A new federal prescription drug site promises to save patients money on popular drugs. Here’s what physicians should know about TrumpRx.

Results of a large cohort study show adherence to a Mediterranean diet is linked to a lower risk for all stroke types in women.

As patients with HIV live longer, menopause is becoming routine, but the science, safety data, and responsibility for managing it are still catching up.

Medicare beneficiaries with cardiovascular disease or risk factors had increased mortality rates and fewer hospitalizations in the later stages of the COVID-19 pandemic.

The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.

Fetal growth restriction and extreme prematurity alter cardiovascular and pulmonary trajectories, with effects that persist from infancy into adult life.

News All Time

Imaging in Athletes: From Emergencies to Prevention

Beyond bones and muscles, imaging evaluates peripheral nerve injuries from compression to laceration; amateurs may be at higher risk due to poor technique and limited rehab access.

Cutaneous Oncology Updates for 2026, With Paul Nghiem, MD, PhD Paul Nghiem, MD, PhD

Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.

REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis

REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis

Tips on Billing Issues in Dermatology Practices, With Daniel Siegel, MD Daniel M. Siegel, MD

Siegel addressed additional points presented in his Maui Derm 2026 session, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'

Discussing Billing Challenges in Dermatology, With Daniel Siegel, MD Daniel M. Siegel, MD

In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis

HCPLive 5 Stories in Under 5: Week of 02/01

HCPLive 5 Stories in Under 5: Week of 02/01

The HCPFive: Top News for Healthcare Providers from the Week of 02/01

The HCPFive: Top News for Healthcare Providers from the Week of 02/01

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

6 Dermatology Headlines You Missed in January 2026

6 Dermatology Headlines You Missed in January 2026

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Expert Consensus on Knowledge Gaps in Dermatology for Skin of Color, With Henry Lim, MD Henry Lim, MD

This interview with Lim highlights knowledge gaps examined by an international expert panel reviewing existing literature on dermatologic disease in skin of color.

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

The Medical Sisterhood: Advocacy and Systemic Change, With Kristi Hawley, DO Mona Shahriari, MD, FAAD, Kristi B. Hawley, DO

This first episode of 2026 highlights ways to advocate for change in healthcare, empowering each other and patients while navigating systemic challenges.

Upadacitinib Safe for Atopic Dermatitis up to 7 Years in Pooled Analysis Findings

Upadacitinib Safe for Atopic Dermatitis up to 7 Years in Pooled Analysis Findings

Recommended News For You

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

Alkem introduces cetuximab under the trade name Cetuxa in India.

The most precise research tools for the deadliest blood cancer have been developed.

Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.

Even when they are not paying attention, children are still learning.

June 20, 2023, Health Bulletin No. 12.

African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis

Recommended Articles For You

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management

Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News

Featured Articles

Featured Events

Featured KOL Videos

1.

What is Mohs micrographic surgery? 8 FAQs about Mohs

2.

Trump slashed US cancer research by 31 percent: Senate report

3.

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

4.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

5.

Fear of hair loss might cause some to reject cancer treatment

1.

A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing

2.

A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer

3.

Unraveling the Genetic Mystery of Hereditary Spherocytosis

4.

Obesity as a major risk factor for cancer

5.

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

2.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

bot